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BACKGROUND: Tuberculous meningitis is the most severe manifestation of tuberculosis. The diagnostic approach of tuberculous meningitis is 
difficult. Combination of clinical, laboratory and radiological 
criteria were used in diagnostic approach of tuberculous 
meningitis. Urinary mycobacterial lipoarabinomannan 
(LAM) antigen detection is a promising diagnostic tool. 
Detection of mycobacterial antigen in concentrated urine 
sample is predicted to improve the positivity rate of the 
qualitative enzyme-linked immunosorbent assay (ELISA) 
diagnostic tool. The purpose of this study is to examine 
the detection ability of a monoclonal antibody qualitative 
ELISA in concentrated and unconcentrated urine of 
tuberculous meningitis patients.
METHODS: This research is a descriptive, cross-
sectionally designed. The study was conducted in the 
Clinical Pathology Department laboratory of Dr. Hasan 
Sadikin Hospital, in July-October 2014. A total of 27 
patients diagnosed as tuberculous meningitis patients were 
Abstract
Introduction
Tuberculosis is one of major health problems in the world, 
the World Health Organization (WHO) in 1993 stated that 
tuberculosis is a global public health emergency.(1-3) In 
2011, the burden of tuberculosis disease is highest in Asia 
and Africa. Indonesia is one country with large burden of 
included and the subjects were classified into possible 
and probable criteria according to consensus criteria. The 
subjects were classified as definite if the cerebrospinal fluid 
culture was positive for Mycobacterial tuberculosis growth. 
The subjects were examined for the presence of LAM in 
unconcentrated and concentrated urine with a monoclonal 
antibody qualitative ELISA method.
RESULTS: Unconcentrated urinary LAM examination 
positivity was 0% while in concentrated urine was 14.8%. 
The positivity of concentrated urinary LAM were higher 
among the definite criteria group.
CONCLUSION: Concentrating urine sample increase 
the positivity rate of urinary LAM detection with ELISA 
method as high as 14.8%. The urinary antigen detection is 
higher among the definite tuberculous meningitis patients.
KEYWORDS: LAM, concentrated urine, tuberculous 
meningitis, qualitative ELISA
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tuberculosis (0.4-0.5 million). The incidence of mortality 
due to tuberculosis is 150-299 deaths per 100,000 population 
in 2011.(1) 
 Tuberculosis can be manifested as pulmonary or 
extrapulmonary tuberculosis.(4) The most severe form 
of tuberculosis is tuberculous meningitis. Diagnosis of 
tuberculous meningitis is difficult and relied on history, 
physical examination, laboratory and radiological 
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capsulatum antigen (17,18), Streptococcus pneumoniae 
(19,20) and Legionella pneumophila (21). It has been shown 
that the sensitivity of the enzyme-linked immunosorbent 
assay (ELISA) method for LAM in unconcentrated urine 
tuberculosis patients without HIV infection was 7%.(22) The 
sensitivity was  increased to 57% by concentrating the urine 
samples 100 times.(22) Population in this study consisted 
of patients with suspected pulmonary, extrapulmonary and 
latent tuberculosis.(22) Gold standard used in this study 
was smear staining with Ziehl-Neelsen method.(22) This 
study did not involve tuberculous meningitis patients.(22) 
To our knowledge, research on LAM antigen detection 
for diagnosis of tuberculosis infection in patients with 
tuberculous meningitis using concentrated urine has not 
been reported.
examination in a scoring system. Consensus scoring 
system is the most widely used scoring system to diagnose 
tuberculous meningitis. One of the important points in the 
diagnosis of tuberculous meningitis with consensus scoring 
system is the presence of Mycobacterial tuberculosis (M. 
tuberculosis) infection somewhere else other than in the 
Central Nervous System (CNS).(5) Diagnostic tests that 
may indicate the presence of M. tuberculosis infection, 
regardless of the anatomic location of the infection, can be 
very helpful in the diagnosis of tuberculous meningitis. 
  The cell wall of M. tuberculosis has a high lipid 
content and composed of a complex, which consists of 
mycolic acid, arabinogalactan and peptidoglycan (MAGP). 
MAGP complex is the largest component of mycobacterial 
wall. Lipoarabinomanan (LAM) is one of the three main 
glycolipids in MAGP complex. Fifteen percent of the dry 
weight of M. tuberculosis’s wall comprises of LAM.(6) 
LAM is a potential antigen, which is able to mark the M. 
tuberculosis infection. LAM is not degraded in the human 
body (7), secreted by infected alveolar macrophages (8) and 
rising levels of this antigen is comparable with the increase 
of bacterial burden (9). LAM size resembles the size of 
myoglobin (17.5 kDa) causing this antigen in its unbound 
form can pass through the glomerular filtration easily on 
people with normal glomerular function so that LAM 
antigen can be detected from urine.(10) 
  The use of urine samples for M. tuberculosis antigens 
detection has several advantages. Urine sample can be 
obtained easily compare with serum and sputum samples. 
Urine can be obtained in large volumes without invasive 
procedure.(11) Urine collection and processing expose 
laboratory workers to lower health risk compare with serum 
and sputum samples. 
 The sensitivity of the LAM antigen examination in 
urine samples ranged between 2.4-93% with a specificity 
ranging from 87-99%.(12-15) The positivity of LAM 
examination in urine was higher in patients with human 
immunodeficiency virus (HIV) infection, particularly in 
patients with cluster of differentiation (CD)4 <200 cells/
μL.(14,16) The wide range of sensitivity in the various 
studies may be influenced by the analytical sensitivity of 
the detection tool. Because of its potential in detecting 
mycobacterial infection, some researchers suggest to 
conduct researches regarding the methods to increase 
sensitivity of the LAM examination.(12-14) Sensitivity 
of antigen detection in body fluids can be improved by 
concentrating the fluid before performing immunoassay 
examination. Concentrating urine samples has been 
shown to increase the detection sensitivity of  histoplasma 
Subjects were patients who had been diagnosed with 
tuberculous meningitis according to Marais scoring system. 
Patients were hospitalized in Neurology Department of Dr. 
Hasan Sadikin Hospital, a tertiary province central hospital. 
Ethical approval was released by Medical Research Ethical 
Committee of Dr. Hasan Sadikin Hospital. The number 
of ethical clearance was LB 04.01/A05/EC/381/IX/2014. 
Examination materials used in this study were urine of 
tuberculous meningitis patients, all samples were taken 
in Dr. Hasan Sadikin Hospital. Determination of sample 
size in this study was based on a sample size formula for 
categorical descriptive study:
Hence, the number of samples needed for this study based 
on the calculation was 27 samples.
        The suspected tuberculous meningitis patients 
with age of 18 years old or older were included. Subjects 
were categorized as possible, probable and definite. The 
categorization of possible and probable were made based on 
consensus score and computed tomography (CT) scan data 
availability. Patients were categorized as definite tuberculous 
meningitis if the cerebrospinal fluid culture indicate positive 
growth of M. tuberculosis (Table 1). Patients without 
CT scan examination data were categorized as possible 
Methods
N=
Zα = 1.96 
p = 0.803
d = 15%
Zα x p x (1-p)____________
d2
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Table 1. Categorization of research subjects.
tuberculous meningitis if the consensus score were 6-9 or 
as probable tuberculous meningitis if the consensus score 
were ≥10. Patients with CT scan data were categorized as 
possible  tuberculous meningitis if the consensus score were 
6-11 or as probable tuberculous meningitis if the consensus 
score were ≥12. This study was  an observational study and 
cross sectionally designed. 
 Material used in this study is unconcentrated and 
concentrated urine from the middle stream portion of 
tuberculous meningitis patients. Patients or the closest 
relatives of the patients were given information regarding 
the procedure of the research. Written consent were taken 
if patients were agree to be involved in the research. Sterile 
urine tube and explanation regarding midstream urine 
collection were given. Urine sample from unconscious 
tuberculous meningitis patients were collected aseptically 
from sterile urine bag. All samples were morning voided 
urine. Samples were pooled and stored at -20°C in less than 
4 hours. At the day of analysis, urine samples were thawed at 
room temperature. To obtain concentrated urine, 5 mL urine 
samples were inserted into the sample room of the static 
concentrator. Concentration process lasts for 15-30 minutes 
and as much as 0.1 mL (100x concentrated) was produced. 
Cerebrospinal fluid cultured with Microscopic Observes 
Drug Susceptibility (MODS) were used as the gold standard 
procedure to classified the subject as definite tuberculous 
meningitis. The presence of LAM in unconcentrated and 
concentrated urine samples were detected with ELISA 
method. ELISA kit used in this study  was manufactured by 
Cusabio Biotech Co. (Human Lipoarabinomannan ELISA 
Kit Lot.C0310041180; Catalog number CSB E09963h). This 
ELISA method employ a double sandwich assay principles. 
Monoclonal antibody was the capture antibody in this 
detection tool. Measurements were made at a wavelength 
of 450 nm. The manufacturer of ELISA kit has determined 
that the cut off was obtained by adding a constant 0.10 to 
the optical density of the blank, the calculated cut off was 
0.118. Measurement result was categorized as positive if 
Results
Characteristics of research subjects were explained in 
Table 2. Most subjects were in the stage 2 of tuberculous 
meningitis. There were 33.3% subjects, classified as 
definite tuberculous meningitis. Only 14.9% subjects 
were diagnosed as tuberculous meningitis patients without 
evidence of tuberculosis on the site other than CNS. 
 The result of LAM detection in unconcentrated and 
concentrated urine of tuberculous meningitis patients with 
monoclonal antibody qualitative ELISA method can be seen 
in the  Table 3. Patients with HIV positive were 29.6% of 
the subject studied. Positivity rate of urinary LAM among 
patients with HIV positive was 12.5%. Positivity rate among 
patients categorized as definite tuberculous meningitis 
was 22.2%. Positivity rate among patients categorized 
as probable was 11.1% and among possible tuberculous 
meningitis patients was 11.1%. Research subjects with a 
positive HIV test results  were 29.6% of all research subjects 
and dominated by male. Based on WHO clinical staging, 
research subjects with HIV in clinical stage 3 and 4 were 
50% and 50%. Positivity of urine LAM in stage 3 was 25% 
but no positivity were found in the group of clinical stage 4.










Regardless of consensus score and CT scan data
the optical density was higher than 0.118 and categorized 
as negative if the optical density was less than 0.118. 
Sample processing and analysis were conducted at Clinical 
Pathology Department laboratory of  Dr. Hasan Sadikin 
Hospital.
Discussion
This study is the first study to examine LAM detection 
in unconcentrated and concentrated urine of tuberculous 
meningitis patients. Examination of LAM in unconcentrated 
and concentrated urine is expected to provide information 
MODS: Microscopic Observes Drug Susceptibility
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to previous studies conducted.(22,24) Most of the research 
subjects were in clinical stage 2 of tuberculous meningitis. 
Most of the research subjects suffering from tuberculosis on 
the site other than CNS, especially in the lungs. 
 Low positivity of LAM detection in the urine 
among patients with pulmonary tuberculosis is consistent 
with previous research.(25) Urine of 22.7% patients with 
pulmonary tuberculosis were detected with LAM .(25) Low 
positivity results in urine LAM examination can be caused 
by immune condition of the research subjects as well as 
detection tool problems. LAM is an antigen that is secreted 
by M. tuberculosis and on it’s way to environment passing 
through the structure of the wall and thus appears as a wall-
forming component.(26,27). M. tuberculosis-secreted LAM 
enters the circulation and is highly immunogenic causing 
humoral and cellular immune responses.(28) Humoral 
immune response in the formation of antibody against LAM 
leads to antibody-LAM complex. LAM in the bound form 
compare with unbound LAM, is more difficult to be detected 
by immunoassay. Impaired humoral immune responses 
increase the proportion of unbound LAM. LAM examination 
positivity in urine is determined by the proportion of 
unbound and bound LAM. Impaired cellular immune 
response leads to disruption of M. tuberculosis proliferation 
inhibition mechanism because cells that involved in cellular 
immune responses play a role in preventing the spread of 
M. tuberculosis.(29) Deficient of cellular immunity leads to 
the proliferation and spread of M. tuberculosis and LAM 
antigen, these account to the increase of bacterial load and 
antigen levels in the circulation in patients which in turn 
may lead to an increase in positivity of LAM detection in 
urine. Research subjects with a positive HIV test results 
were 29.6% of all research subjects and dominated by male. 
Based on WHO clinical staging, research subjects with HIV 
in clinical stage 3 and 4 were 50% and 50%. Positivity  in 
the group of subjects with HIV clinical stage 3 was 25% and 
no positivity was found in clinical stage 4 group. The higher 
positivity in clinical stage 3 group compared to clinical 
stage 4 group is contradictory with the lower immunity state 
of clinical stage 4 group.  
 Low positivity rate found in this study could be caused 
by the problem in the LAM ELISA kit detection limit. If the 
concentration of LAM in the sample studied was lower than 
the detection limit of the LAM ELISA kit, the examination 
will give negative result. The limit of detection is the lowest 
analyte concentration with the results of measurements that 
can be distinguished from blank.(30) Information regarding 
limit of detection was not provided by the manufacturer, thus 
the problem of detection limit in this study was recognized 
Characteristics n (%)
   Age (year)
     - Median 33
     - Range  19-64
   Gender 
     - Male 18 (66.67%)
     - Female 9 (33.33%)
   Clinical stage of tuberculous 
   meningitis *
     - Stage 1 4 (14.8%)
     - Stage 2 19 (70.4%)
     - Stage 3 4 (14.8%)
   Diagnosis Classification of 
   tuberculous meningitis **
     - Possible 9 (33.3%)
     - Probable 9 (33.3%)
     - Definite 9 (33.3%)
   Tuberculosis in the site other 
   than CNS  
     - Only pulmonary tuberculosis 17 (62.9%)
     - Disseminate tuberculosis 6 (22.2%)
     - Without tuberculosis on the site 
       other than CNS
4 (14.9%)
   HIV Infection 
     - Positive 8 (29.6%)
     - Negative 14 (51.8%)
     - No data of HIV infection 5 (18.6%)
LAM (+) LAM (-)
Unconcentrated Urine 0 27 (100%)
Concentrated Urine 4 (14.8%) 23 (85.2%)
LAM Detection with 
Qualitative ELISA
Table 2. Characteristic of research subjects.
Table 3. The result of LAM detection in unconcentrated and 
concentrated urine of tuberculous meningitis patients.
about the role of concentrating urine sample to improve the 
performance of  M. tuberculosis antigen detection tool. The 
use of monoclonal antibody as capture antibody is expected 
to improve the specificity of the detection tool. 
 Research subjects in this study were in the age range 
of  18-64 years, this age range is not much different compare 
* According to British Royal Medical Council 
**According to Consensus Scoring system
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The effort to concentrate urine sample of tuberculous 
meningitis patients produce a low increment of positivity 
rate as much as 14.8% thus detection of mycobacterial 
LAM with qualitative monoclonal ELISA is insignificantly 
improved with this  effort.
 Further study is needed to quantify the difference 
in diagnostic advantage between the usage of static and 
centrifugal concentrators for urine samples. Detection of 
LAM from urine samples for screening purposes might 
be better done with polyclonal antibody coated ELISA 
kit compared to monoclonal antibody coated ELISA kit, 
however further studies is also required to back up this 
statement. 
Conclusion
after researchers conducted a study to compare concentrated 
urine with 100x-diluted of concentrated urine. LAM 
examination of concentrated urine gave positive results, 
whereas LAM examination of 100x-diluted concentrated 
urine gave negative results. Results of these experiments 
indicated that the presence of LAM antigen in 100x diluted 
concentrated urine could not be detected by the ELISA kit. 
This experiment indicated that there was a certain detection 
limit of the ELISA kit. To investigate LAM detection limit 
of this ELISA kit may need further investigation.
 This study used  morning voided urine as sample, 
in order to obtain the most concentrated urine sample. 
Furthermore, the urine samples were concentrated with 
static concentrators. This efforts were expected to increase 
the levels of antigen per unit volume of urine. Savolainen 
studied the similar effort to concentrate urine samples 100x, 
this study showed that the efforts can increase the ELISA 
sensitivity in detecting LAM antigen from 7% to 57%.(22) 
The results of Savolainen study could not be reproduced, 
since there are differences in the tools being used. This 
study used Cusabio® ELISA kit and static concentrators, 
previous study done by Savolainen used Clearview® 
ELISA kit and centrifugal concentrators.(22) Centrifugal 
concentrator utilizing centrifugation force. Centrifugal 
force can overcome the problem of the filter blockade that 
can be found in the static concentrators.(31) Centrifugator 
with larger bucket diameters is needed by centrifugal 
concentrators, this type of centrifugator is not available in 
most clinical laboratories. Static concentrators were chosen 
because this type of concentrator do not require installment 
of new and costly equipment. The difference in ELISA kit 
and concentrator used can be the cause of different results 
between this study and Savolainen study. 
 Reither experienced this problem when was trying 
to reproduce the results of  Boehme study. Boehme’s and 
Reither’s studies used different ELISA kits, although 
from the same manufacturer.(23,25) Reither analyzed 
the differences in the results of his research with the one 
of Boehme and came to conclusion that the manufacturer 
performed different producing methods for the ELISA 
kits. The most distinguishable difference of manufacturing 
method was in antibody coating method. Thus, Reither 
concluded that difference in ELISA kit manufacturing 
methods can cause differences in the results.(25) Savolainen 
used qualitative ELISA kit with polyclonal antibody as the 
capture antibody.(22) This study used qualitative ELISA 
kit with monoclonal antibody as the capture antibody. The 
use of monoclonal antibodies for the detection of antigens 
have the advantage of being able to increase the specificity 
of the examination and reduce the possibility of batch to 
batch variation which is commonly encountered in the use 
of polyclonal antibodies. The use of monoclonal antibody 
to increase specificity at the expense of sensitivity may be 
lower, thus lowering the positivity rate.
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